The contract research organization posted revenue of $2.02 billion in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $1.99 billion. Icon PLC expects full-year ...

2d. ICON plc ICLR is well-poised to grow in the upcoming quarters, driven by its strategic additions. Leveraging AI and technology advancements, ...

It has been about a month since the last earnings report for Icon PLC (ICLR). Shares have lost about 9.7% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Icon PLC (ICLR) came out with quarterly earnings of $3.19 per share, beating the Zacks Consensus Estimate of $3.08 per share. This compares to earnings of $3.47 per share a year ago. These figures ...

More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain ...

Icon Plc (NASDAQ:ICLR) is a contract research organization (“CRO”). In the Q3 2024 letter, I highlighted our investment in Medpace another CRO that directly competes with Icon.

Investors might want to bet on Icon PLC (ICLR), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial intelligence (AI) tools ...

Overall Count and Share for 'ICON plc' based on the 12-month time frame mentioned above. Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research ...

A month has gone by since the last earnings report for Icon PLC (ICLR). Shares have lost about 8.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

ICON plc is a world-leading healthcare intelligence and clinical research organization. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, ...